How can Tuberculosis (TB) cause hemoptysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tuberculosis (TB) causes hemoptysis primarily through direct damage to lung tissue and blood vessels, leading to the erosion of bronchial arteries and the formation of abnormal blood vessels prone to rupture. The mechanism of TB-induced hemoptysis involves the formation of granulomas, which can undergo necrosis and cavitation, creating cavities in the lung tissue that contain exposed and damaged blood vessels 1. As the disease progresses, the erosion of these blood vessels results in bleeding into the airways, ranging from mild to severe hemoptysis. Additionally, TB can cause the formation of Rasmussen's aneurysms, which are prone to rupture and cause significant bleeding, and lead to bronchiectasis, a condition that further contributes to hemoptysis 1. The treatment of hemoptysis due to TB requires prompt initiation of a standard anti-TB regimen, and in cases of massive hemoptysis, bronchial artery embolization (BAE) has become a first-line therapy, with high success rates, as reported in recent studies 1. Some of the key studies that support the use of BAE in the treatment of hemoptysis include those by Pei et al, Bhalla et al, Shao et al, Agmy et al, Woo et al, and Shin et al, which demonstrate high success rates and low recurrence rates for BAE in patients with massive hemoptysis due to TB or other causes 1. Overall, the management of hemoptysis due to TB requires a comprehensive approach that includes prompt treatment with anti-TB medications and consideration of BAE in cases of severe bleeding. Key points to consider in the management of TB-induced hemoptysis include:

  • Prompt initiation of anti-TB therapy
  • Consideration of BAE in cases of massive hemoptysis
  • Monitoring for complications such as bronchiectasis and Rasmussen's aneurysms
  • Individualized treatment approaches based on the severity of hemoptysis and the presence of underlying lung disease.

From the Research

Causes of Hemoptysis in Tuberculosis

  • Tuberculosis (TB) can cause hemoptysis due to the damage it inflicts on the lungs and airways 2, 3.
  • The most common causes of hemoptysis are tuberculosis, lung carcinoma, and bronchiectasis, but idiopathic forms are frequent 3.
  • In TB, hemoptysis can occur due to inflammatory hypervascularity, contrast material extravasation, and pseudoaneurysms 2.

Mechanism of Hemoptysis in TB

  • Blood originates most often from bronchial circulation, which can be affected by TB 3.
  • The disease can cause damage to the lung tissue, leading to the formation of cavities and the rupture of blood vessels, resulting in hemoptysis 2, 4.

Treatment and Management

  • The management of life-threatening hemoptysis is mainly based on either surgical approach or bronchial artery embolization 3.
  • Bronchial artery embolization is an effective and safe technique in the management of life-threatening hemoptysis secondary to tuberculosis 2, 4.
  • The treatment of TB itself involves the use of antibiotics, such as isoniazid, rifampin, pyrazinamide, and ethambutol, which can help to reduce the risk of hemoptysis 5, 6.

Outcomes and Complications

  • The hemoptysis control rate was 86.6% at 14 days, 84.8% at 30 days, 78.6% at 240 days, and 75.9% at 360 days, respectively, after bronchial artery embolization 4.
  • Patients with active tuberculosis had a significantly longer recurrence-free duration than did patients with inactive tuberculosis 4.
  • The most common complication of bronchial artery embolization was transient chest pain 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Hemoptysis].

La Revue du praticien, 2003

Research

Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2002

Research

The Treatment of Tuberculosis.

Clinical pharmacology and therapeutics, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.